Jublia and Pleural effusion - a phase IV clinical study of FDA data

Summary:

Pleural effusion is reported as a side effect among people who take Jublia (efinaconazole), especially for people who are female, 60+ old, also take Nitroglycerin, and have Asthma.

The phase IV clinical study analyzes which people have Pleural effusion when taking Jublia. It is created by eHealthMe based on reports of 1,769 people who have side effects when taking Jublia from the FDA, and is updated regularly.

What is Jublia?

Jublia has active ingredients of efinaconazole. eHealthMe is studying from 1,780 Jublia users. Check the latest studies of Jublia.

What is Pleural effusion?

Pleural effusion (water on the lungs) is found to be associated with 2,219 drugs and 3,150 conditions by eHealthMe. Check the latest studies of Pleural effusion.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

1,769 people reported to have side effects when taking Jublia.
Among them, 64 people (3.62%) have Pleural effusion.

Among these 64 people:

What is the gender of people who have Pleural effusion when taking Jublia? *

female: 90.32 %
male: 9.68 %

What is the age of people who have Pleural effusion when taking Jublia? *

What are other drugs people take besides Jublia? *

What are other side effects people have besides Pleural effusion? *

Cough: 59 people, 92.19%
Wheezing (a high-pitched whistling sound made while you breath): 58 people, 90.62%
Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection): 58 people, 90.62%
Bronchopulmonary Aspergillosis Allergic (allergic lung disorder caused by aspergillus fungi): 58 people, 90.62%
Pneumonia: 58 people, 90.62%
Oedema Peripheral (superficial swelling): 58 people, 90.62%
Obstructive Airways Disorder (a progressive disease that makes it hard to breathe): 58 people, 90.62%
Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 58 people, 90.62%
Constipation: 58 people, 90.62%
Lower Respiratory Tract Infection: 58 people, 90.62%

What are the existing conditions these people have? *

Asthma: 56 people, 87.50%
Dyspnea (difficult or laboured breathing): 14 people, 21.88%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 12 people, 18.75%
Constipation: 11 people, 17.19%
The Flu (the flu is caused by an influenza virus): 10 people, 15.62%
Sleep Disorder: 3 people, 4.69%
Pain: 3 people, 4.69%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 4.69%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 3 people, 4.69%
Bacterial Infection: 3 people, 4.69%

* Approximation only. Some reports may have incomplete information.

Do you take Jublia and have Pleural effusion?

- Check whether Pleural effusion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Jublia:

Jublia (1,780 reports)

Pleural effusion treatments and more:

Pleural effusion (84,634 reports)

Browse all side effects of Jublia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pleural effusion:

Pleural effusion (2,219 drugs)

Browse all the conditions that are associated with Pleural effusion:

Pleural effusion (3,150 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on efinaconazole (the active ingredients of Jublia) and Jublia (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.